Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
08/08/2007 | CN101011486A Medicine for treating gynecological inflammation disease and its preparation process |
08/08/2007 | CN101011485A Externally used soup for burn and scald |
08/08/2007 | CN101011482A Pharmaceutical compositions for the treatment of acne |
08/08/2007 | CN101011465A Medical ointment for treating chilblain and its preparing process |
08/08/2007 | CN101011463A Use of perilla oil in the preparation of medicament preparation for preventing and treating osteoporosis and skin senescence |
08/08/2007 | CN101011460A Pharmaceutical composition with both depigmenting and whitening effects |
08/08/2007 | CN101011458A Traditional Chinese medicine formulation for treating ulcer |
08/08/2007 | CN101011456A Externally used antiphlogistic anti-allergic medicament stilbene pine cream for skin side effect of cortical hormone |
08/08/2007 | CN101011446A Application of total saponin from platycodon grandiflorum in pharmacy and cosmetic product |
08/08/2007 | CN101011444A Externally used traditional Chinese medicine and its preparing process |
08/08/2007 | CN101011434A Yew podocarpus leaf preparation and its preparation method |
08/08/2007 | CN101011433A Medicinal liquor for treating skin disease and trauma |
08/08/2007 | CN101011431A Traditional Chinese medicine for health preserving and beauty improving |
08/08/2007 | CN101011427A Chinese traditional medicine for treating Cazenave's lupus and sclerodermas |
08/08/2007 | CN101011392A Amino acid composition for enhancing traumatic organism growth factor expression and oxidation resistance function |
08/08/2007 | CN101011058A Disinfectant and/or bactericidal aqueous compositions |
08/07/2007 | US7253341 Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same, their uses and methods of increasing a specific activity thereof |
08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
08/07/2007 | US7253284 Chemical compounds |
08/07/2007 | US7253254 Polypeptide variants with increased heparin-binding capacity |
08/07/2007 | US7253199 Azole derivatives and pharmaceutical compositions containing them |
08/07/2007 | US7253194 Compounds and inhibitors of phospholipases |
08/07/2007 | US7253191 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry |
08/07/2007 | US7253187 Heterocyclic inhibitors of ERK2 and uses thereof |
08/07/2007 | US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis. |
08/07/2007 | US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents |
08/07/2007 | US7253155 Combination of a tetra-substituted pyrimidopyrimidine, and a corticosteroid simultaneously or within 14 days of each other |
08/07/2007 | US7252845 Synergistic compositions containing aromatic compounds and terpenoids present in Alpinia galanga |
08/07/2007 | US7252799 Methods for sterilizing preparations containing albumin |
08/07/2007 | CA2376379C Modified chimeric polypeptides with improved pharmacokinetic properties |
08/07/2007 | CA2351536C Therapeutic anti-fungal nail preparation |
08/07/2007 | CA2324001C Retinoid-like compounds for the promotion of melanin production |
08/07/2007 | CA2317589C Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
08/02/2007 | WO2007086584A1 NOVEL INHIBITOR OF FabK AND FabI/K |
08/02/2007 | WO2007086582A1 OIL-IN-WATER TYPE EMULSION LOTION CONTAINING 22-OXA-1α,25-DIHYDROXYVITAMIN D3 AND METHOD OF TREATING SKIN DISEASE BY USING THE SAME |
08/02/2007 | WO2007086573A1 Agent for preventing or improving disease caused by candida infection and oral composition |
08/02/2007 | WO2007086565A1 Growth hormone secretion regulator |
08/02/2007 | WO2007085681A1 Treatment substance containing magnesium salts for treatment of tumors or like and use of magnesium salts |
08/02/2007 | WO2007085652A1 Use of the (s) enantiomer of mequitazine for preparing a medicament, while at the same time limiting genomic toxicity |
08/02/2007 | WO2007085626A1 Purification and use of a factor for supporting wound healing |
08/02/2007 | WO2007085086A1 A composition including a silicone-based polymer and a method of treating skin disorders using the composition |
08/02/2007 | WO2007068841A3 Use of a composition based on tretinoin, hydroquinone and fluocinolone acetonide, accompanied by a chemical peeling |
08/02/2007 | WO2007065289A3 4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders |
08/02/2007 | WO2007059905A3 Thienopyrimidines treating inflammatory diseases |
08/02/2007 | WO2006137100A3 Molecular complex comprising arbutine, ascorbic acid, oleuropeina or its derivatives thereof and related uses in medical field |
08/02/2007 | US20070179297 Chemical compounds |
08/02/2007 | US20070179150 Nitrosated proton pump inhibitors, compositions and methods of use |
08/02/2007 | US20070179118 Use as inhibitors of cyclin-dependent kinases 4 (cdk4); treating proliferative disorders such as cancer; salt of 6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one for example |
08/02/2007 | US20070179101 biodrug as antitumor agent, a vaccine adjuvant for infections and cancers, and antiallergy agents |
08/02/2007 | US20070179087 Method for treating inflammatory diseases using heat shock proteins |
08/02/2007 | US20070178079 lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions; lactobacilli, bifidobacteria or Enterococci |
08/02/2007 | DE102006004327A1 Chromen-4-on-Derivate Chromen-4-one derivatives |
08/02/2007 | CA2640010A1 Purification and use of a factor for supporting wound healing |
08/02/2007 | CA2637447A1 A composition including a silicone-based polymer and a method of treating skin disorders using the composition |
08/01/2007 | EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby |
08/01/2007 | EP1813286A2 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
08/01/2007 | EP1813284A1 Pharmaceutical composition |
08/01/2007 | EP1813278A1 Nucleoside analogs with carboxamidine modified monocyclic base |
08/01/2007 | EP1813269A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
08/01/2007 | EP1813250A1 External preparation |
08/01/2007 | EP1812451A2 Compounds and methods of use thereof |
08/01/2007 | EP1812441A1 1,4 substituted pyrazolopyrimidines as kinase inhibitors |
08/01/2007 | EP1812374A1 Novel salts of fumaric acid monoalkylesters and their pharmaceutical use |
08/01/2007 | EP1812034A1 Compositions and methods for inducing melanogenesis in a subject |
08/01/2007 | EP1812029A1 Composition comprising extract of anemarrhena asphodeloides and aralia elata, and use thereof |
08/01/2007 | EP1811990A1 Anti-demodicosis agent |
08/01/2007 | EP1572071A4 Systems and methods for treating patients with processed lipoaspirate cells |
08/01/2007 | EP1546130B1 Piperidine derivatives for use in the treatment of chemokine mediated disease states |
08/01/2007 | EP1507760B1 Cyanoguanidine prodrugs |
08/01/2007 | EP1461326B1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
08/01/2007 | EP1419158B1 Pteridinone derivatives as modulators of chemokine receptor activity |
08/01/2007 | EP1393732B1 Minoxidil-containing liquid composition |
08/01/2007 | EP1381681B1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
08/01/2007 | EP1259235B1 Tyrosine kinase inhibitors |
08/01/2007 | EP1187592B1 Alpha v integrin receptor antagonists |
08/01/2007 | EP1066816B1 Agents promoting laminin production in skin cells |
08/01/2007 | CN1329409C Modulation of the expression of genes dependent on STAT-1 |
08/01/2007 | CN1329393C New purine derivatives |
08/01/2007 | CN1329388C 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors |
08/01/2007 | CN1329374C Compound as CCR5 agonist |
08/01/2007 | CN1329372C Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
08/01/2007 | CN1329068C Scarless wound healing ointment |
08/01/2007 | CN1329053C Externally applied agent for treating wean hives |
08/01/2007 | CN1329032C Non-sedating barbiturate compounds as neuroprotective agents |
08/01/2007 | CN1329028C Ointment for quick curing trauma of burn and scald |
08/01/2007 | CN1329025C Gels comprising at least one retinoid and benzoyl peroxide |
08/01/2007 | CN101010102A Composition comprising non-oxidizable fatty acid analogoues and plant and/or fish oils |
08/01/2007 | CN101010101A Composition comprising protein material and non-oxidizable fatty acid entities |
08/01/2007 | CN101010084A A composition containing a thiourea derivative for preventing or treating pruritic or irritant skin diseases |
08/01/2007 | CN101010077A Use of targeted oxidative therapeutic formulation in treatment of burns |
08/01/2007 | CN101010076A Immune function-improving agent |
08/01/2007 | CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
08/01/2007 | CN101007169A A microcapsule of egg yolk immunoglobulin, preparing process and use thereof |
08/01/2007 | CN101007139A An external applied medicine for treating burn and scald |
08/01/2007 | CN101007111A An externally appplied medicine for treating rheumatic diseases |
08/01/2007 | CN101007109A Medicine composition containing metronidazoline |
08/01/2007 | CN101007108A Chinese-western medicine composition containing azelaic acid for treating acne |
08/01/2007 | CN101007107A Composition containing tazarotene |
08/01/2007 | CN101007106A Composition containing tinidazole |
08/01/2007 | CN101007105A Chinese-western medicine composition containing spironolactone |